InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: xoc post# 84762

Sunday, 01/04/2015 12:08:30 AM

Sunday, January 04, 2015 12:08:30 AM

Post# of 403755
XOC, perhaps the update at the Biotech conference on Kevetrin..where exactly its at right now will let us know if it has a chance at getting anything in at ASCO at best it would have to be in the late breaking category. I would not be surprised if the company already is planning on Brilacidin-OM presentation there.